Cryptosporidiosis Drug Discovery: Opportunities and Challenges
- PMID: 27626293
- DOI: 10.1021/acsinfecdis.6b00094
Cryptosporidiosis Drug Discovery: Opportunities and Challenges
Abstract
The apicomplexan parasite Cryptosporidium is the second most important diarrheal pathogen causing life-threatening diarrhea in children, which is also associated with long-term growth faltering and cognitive deficiency. Cryptosporidiosis is a parasitic disease of public health concern caused by Cryptosporidium parvum and Cryptosporidium hominis. Currently, nitazoxanide is the only approved treatment for cryptosporidium infections. Unfortunately, it has limited efficacy in the most vulnerable patients, thus there is an urgent need for a safe and efficacious cryptosporidiosis drug. In this work, we present our current perspectives on the target product profile for novel cryptosporidiosis therapies and the perceived challenges and possible mitigation plans at different stages in the cryptosporidiosis drug discovery process.
Keywords: Cryptosporidium; cryptosporidiosis; diarrhea; drug discovery; target product profile.
Similar articles
-
Cryptic parasite revealed improved prospects for treatment and control of human cryptosporidiosis through advanced technologies.Adv Parasitol. 2011;77:141-73. doi: 10.1016/B978-0-12-391429-3.00007-1. Adv Parasitol. 2011. PMID: 22137584 Review.
-
Phenotypic screening techniques for Cryptosporidium drug discovery.Expert Opin Drug Discov. 2021 Jan;16(1):59-74. doi: 10.1080/17460441.2020.1812577. Epub 2020 Sep 7. Expert Opin Drug Discov. 2021. PMID: 32892652 Review.
-
A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.PLoS Negl Trop Dis. 2017 Feb 3;11(2):e0005373. doi: 10.1371/journal.pntd.0005373. eCollection 2017 Feb. PLoS Negl Trop Dis. 2017. PMID: 28158186 Free PMC article.
-
Advances in therapeutic and vaccine targets for Cryptosporidium: Challenges and possible mitigation strategies.Acta Trop. 2022 Feb;226:106273. doi: 10.1016/j.actatropica.2021.106273. Epub 2021 Dec 11. Acta Trop. 2022. PMID: 34906550 Review.
-
Recent advances in genetic manipulation of Cryptosporidium.Curr Opin Microbiol. 2020 Dec;58:146-152. doi: 10.1016/j.mib.2020.09.010. Epub 2020 Nov 5. Curr Opin Microbiol. 2020. PMID: 33161368 Free PMC article. Review.
Cited by
-
Anti-Cryptosporidial Drug-Discovery Challenges and Existing Therapeutic Avenues: A "One-Health" Concern.Life (Basel). 2024 Jan 3;14(1):80. doi: 10.3390/life14010080. Life (Basel). 2024. PMID: 38255695 Free PMC article. Review.
-
Editorial: Drug Development for Parasite-Induced Diarrheal Diseases.Front Microbiol. 2017 Apr 4;8:577. doi: 10.3389/fmicb.2017.00577. eCollection 2017. Front Microbiol. 2017. PMID: 28421063 Free PMC article. No abstract available.
-
Bicyclic azetidines kill the diarrheal pathogen Cryptosporidium in mice by inhibiting parasite phenylalanyl-tRNA synthetase.Sci Transl Med. 2020 Sep 30;12(563):eaba8412. doi: 10.1126/scitranslmed.aba8412. Sci Transl Med. 2020. PMID: 32998973 Free PMC article.
-
Prevalence of Cryptosporidium spp. in children and the elderly in southwestern Iran.Gastroenterol Hepatol Bed Bench. 2022;15(4):415-420. doi: 10.22037/ghfbb.v15i4.2619. Gastroenterol Hepatol Bed Bench. 2022. PMID: 36762223 Free PMC article.
-
Recent Breakthroughs and Ongoing Limitations in Cryptosporidium Research.F1000Res. 2018 Sep 3;7:F1000 Faculty Rev-1380. doi: 10.12688/f1000research.15333.1. eCollection 2018. F1000Res. 2018. PMID: 30228873 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical